Try our ⁠⁠LinguaSimplify⁠⁠ app.

This episode explores Spain’s growing medicine shortage, affecting over 1,100 pharmaceutical products, and the EU’s heavy reliance on China and India for active ingredients. We discuss the geopolitical and logistical risks behind this dependence, the difference between minor and critical drug shortages, and how initiatives like Spain’s Supply Guarantee Plan and the EU’s Critical Medicines Act aim to boost local production and strengthen pharmaceutical autonomy.